How can I break into industry if my CV keeps disappearing into a black hole?

Autor: Lizak M

Publikováno v: Nature [Nature] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.

I help researchers build fantastic funding proposals - here's how.

Autor: Lizak M

Publikováno v: Nature [Nature] 2024 Feb 26. Date of Electronic Publication: 2024 Feb 26.

Scientific utopias: scientific enlightenment in the Stupid Questions Office.

Autor: Lizak M

Publikováno v: Nature [Nature] 2023 Jun 05. Date of Electronic Publication: 2023 Jun 05.

Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients.

Autor: Nicoli ER; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Huebecker M; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Han ST; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Garcia K; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Munasinghe J; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD, United States., Lizak M; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD, United States., Latour Y; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Yoon R; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Glase B; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States., Tyrlik M; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States., Peiravi M; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States., Springer D; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States., Baker EH; Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, United States., Priestman D; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Sidhu R; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States., Kell P; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States., Jiang X; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States., Kolstad J; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States., Kuhn AL; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States., Shazeeb MS; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States., Acosta MT; Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, MD, United States., Proia RL; Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States., Platt FM; Department of Pharmacology, University of Oxford, Oxford, United Kingdom., Tifft CJ; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, MD, United States. Electronic address: cynthiat@mail.nih.gov.

Publikováno v: Molecular genetics and metabolism [Mol Genet Metab] 2023 Feb; Vol. 138 (2), pp. 107508. Date of Electronic Publication: 2023 Jan 13.

Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation.

Autor: Gao JL; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Weaver JD; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Tuo J; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Wang LQ; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Siwicki M; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Despres D; Mouse Imaging Facility, National Institutes of Health, Bethesda, MD, USA., Lizak M; Mouse Imaging Facility, National Institutes of Health, Bethesda, MD, USA., Schneider EH; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Kovacs W; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Maminishkis A; Section on Epithelial and Retinal Physiology and Disease, National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Chen K; Laboratory of Cancer and Immunometabolism, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA., Yoshimura T; Department of Pathology and Experimental Medicine, Okayama University, Okayama, Japan., Ming Wang J; Laboratory of Cancer and Immunometabolism, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA., Chao Chan C; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2021 Feb; Vol. 35 (2), pp. e21315.